Objectives: Cesarean myomectomy (removal of fibroids during cesarean section) prevents an additional surgery, the cost, associated complications, and the physical and psychological trauma. However, there is risk of increased bleeding. Nevertheless, many centers practice it taking optimum precautions. The aim of our study was to compare cesarean myomectomy patients in those women who underwent cesarean section without fibroid removal for (a) blood loss, fall in hemoglobin, blood transfusion requirement; (b) intraoperative and postoperative complications; and (c) duration of hospitalization.
INTRODUCTION
Cesarean myomectomy refers to the removal of fibroids during cesarean sections. Fibroids are benign neoplasms of uterine musculature causing problems like menstrual disturbances, pain, infertility, abortions, dysfunctional or obstructed labor, and postpartum hemorrhage.
Myomectomy at the time of cesarean delivery was feared because of the risk of hemorrhage. This had deprived numerous women from the opportunity of freedom from this malady at the same sitting of cesarean section forcing them either to continue suffering from the problems due to fibroids or to endure another surgery in the name of treatment. If fibroids can be removed concurrently with cesarean section, it could reduce the intraop complications (like injury due to adhesions, anesthesia complications, bleeding) and postoperative complications asso ciated with an additional surgery.
Studies are now under way and some are complete, which have shown encouraging results favoring concurrent myomectomy during cesarean section without the dreaded complication of significant hemorrhage.
A retrospective study was performed to determine whether myomectomy at the time of cesarean delivery leads to an increased incidence of intrapartum and shortterm postpartum complications. They were compared against a group for which fibroid removal was omitted where emergency cesarean section had been performed.
REVIEW OF LITERATURE
Myomectomy at the time of cesarean delivery had been earlier considered a formidable procedure with the lurking threat of life-threatening hemorrhage. With the exception of small, pedunculated fibroids, most of the leading obstetrics textbooks advise against myomectomy during cesarean delivery due to theoretical risks of intractable hemorrhage and increased postoperative morbidity. 1, 2 In the medical literature, however, there are few studies that directly address this controversy. There are some case series and anecdotes that give mixed results. [3] [4] [5] [6] [7] [8] Across the world many institutions have, however, started embarking on the procedure cautiously lured by the proposed advantages. In an attempt to define the risks of myomectomy during cesarean delivery, we look at the past 5-year experience at our institution with the procedure.
OBJECTIVES
To determine whether myomectomy at the time of cesarean delivery leads to an increased incidence of hemorrhage and perioperative morbidity, and to identify subgroups that may be at a higher risk of developing intrapartum hemorrhage. 
JSAFOG

These women fulfilled the following criteria: (1) Documented fibroid uterus during the index pregnancy by antepartum ultrasound or by intraoperative findings; (2) delivery by cesarean section; (3) admission and postpartum hematocrits in the database; (4) no evidence of antenatal bleeding (e.g., from placenta praevia or abruption); (5) no other procedures at the time of cesarean delivery besides myomectomy (e.g., cystectomy, myolysis, or planned hysterectomy); and (6) no comorbid conditions with evidence of coagulopathy.
Characteristics compared include age, parity, gestational age at delivery, type of cesarean performed, and size and location of fibroid. In the myomectomy group, the size of the excised fibroid was obtained from the pathology reports and operation notes.
Primary outcomes analyzed were change in hematocrit, postpartum fever, operative time, and duration of hospitalization. Hemorrhage was analyzed based on blood loss, fall in hemoglobin from preoperative value to the postoperative value, or the need for intraoperative transfusion. Fever was defined as postoperative temperature greater than or equal to 37.6°C.
MATERIALS AND METHODS
The medical records of cesarean sections done at our institution on women with fibroids were studied.
Sample size was determined based on the average number of antenatal women attending the antenatal clinic over the previous 3 years who had undergone cesarean section for various indications. A total of 76 cases were found over 5 years, of which in 37 women myomectomy had been done concurrently with cesarean section and 39 in which myomectomy had been omitted.
PROCEDURE
The women in either group had given informed consent for cesarean section alone or for cesarean along with myomectomy. In the myomectomy group, in case of fibroids larger than 4 cm, prophylactic uterine artery ligation had been done after cesarean before starting myomectomy. The blood loss is routinely measured in our institution by weighing the soaked pads and from the collection in the suction drain. Preoperative and postoperative hemoglobin had been measured and the fall in hemoglobin was recorded as mentioned in Table 3 and Graph 3. The number of units of blood transfusion, if required, any intraop or postop complication was duly noted and documented. The duration of hospital stay Table 6 and Graph 6 was also documented (after excluding prolongation of stay required for the sake of the baby).
All data were analyzed using Pearson's chi-squared test for categorical variables and student t test for continuous variables. The threshold of significance was defined as p < 0.05.
RESULTS
The demographic variables of age; socioeconomic status; previous mode of delivery; and methods of diagnosis of fibroid average number, type, location, and size were found comparable in the two groups possibly since the women came from a common indigenous background. There had been no incidence of red degeneration of fibroid in either group.
The distribution of indications for cesarean being obstetric or fibroid per se in either group had also been comparable.
On analysis of outcomes no difference was found in estimated blood loss (Graphs 1 to 3), need for transfusion (Graphs 4 and Table 4 ) or intraoperative injuries. Statistically significant increase was seen in febrile morbidity in myomectomy group (Table 5 and Graph 5) which however did not translate into a prolonged hospital stay (Table 6 and Graph 6). In other words they were easily controlled with supportive therapy (hydration, antibiotics).
(1) Estimated blood loss There was no increase in units of blood transfused in the myomectomy group. On the contrary, one patient in nonmyomectomy group had increased need for transfusion. It was, however, due to bleeding from inferior epigastric artery.
There was no significant increase in the incidence of intraoperative injuries in the myomectomy group.
There was no significant increase in hemoglobin fall in the myomectomy group.
There was a significant increase in febrile morbidity in the myomectomy group. However, the cases included respiratory and urinary tract infections, which could be treated easily and also did not prolong hospital stay in the patients concerned. 
DISCUSSION
The numerous problems caused by fibroids in nonpregnant individuals as well as in their ensuing pregnancies are cause enough for their removal, more so in a developing country like ours where an interval myomectomy would only add economic woes to the physical and mental trauma endured by the patient.
Removal of fibroids can have the following benefits apart from the cost effectiveness of the procedure: • Prevent injuries due to adhesions in subsequent surgeries.
• Prevent menstrual abnormalities, complications in subsequent pregnancies due to fibroids, as earlier mentioned.
• A lower segment fibroid if removed helps in putting a lower segment incision and possible trial of labor in the next pregnancy. 9 • Scar integrity in cesarean myomectomy found to be better than that of interval myomectomy as documented by ultrasound subsequently. 10 The results of our study showed that myomectomy done with caesarean section did not increase the rate of haemorrhage as seen from Tables 1 to 3. Table 4 and Graph 4 indicate that there was no increase in intraoperative complications in the myomectomy group.
CONCLUSION
In properly selected cases, myomectomy done during cesarean section does not increase the morbidity or mortality rate. Proper caution has to be, however, exercised by ensuring adequate availability of blood for transfusion, experienced surgeons able to detect and tackle intraop complications, use of bilateral uterine artery ligation, 11 and electrocautery 10 in large fibroids.
The advantages of caesarean myomectomy as mentioned earlier could compensate for the minor increase in febrile morbidity (Table 5 and Graph 5) in the myomectomy group .
Nevertheless, large randomized multicenter trials and studies to follow up long-term obstetric consequences may still be required before the final word could be said!
